Intellectual Property Strategy – The Foundation of Long-Term Value
At Ausovi, Intellectual Property Strategy is not an afterthought — it is a foundational, cross-functional discipline embedded from the earliest stages of discovery through preclinical advancement and portfolio maturation. We recognize that in the competitive landscape of novel analog therapeutics, strong, layered, and strategically timed IP is the single most important driver of long-term commercial value, partnership attractiveness, and exit potential.
By integrating IP strategy deeply into every scientific decision, Ausovi ensures that:
- Every program advances with strong, defensible IP from day one
- Novelty and non-obviousness are maximized through early, broad filings
- Freedom-to-operate risks are identified and mitigated before significant investment
- Portfolio value is continuously enhanced through layered, follow-on protection
- Partnership and exit options remain flexible and attractive
This disciplined, forward-looking IP approach is resource-intensive by design — because in biotechnology, unprotected innovation has limited value. A robust IP estate built around novel analog therapeutics transforms scientific breakthroughs into durable commercial assets capable of delivering long-term benefit to patients and substantial returns to stakeholders.
The IP Strategy
Many promising therapeutic programs fail to realize full commercial potential due to narrow or late-stage IP: weak composition claims, unprotectable scaffolds, freedom-to-operate roadblocks, or insufficient follow-on protection that allows competitors to design around or enter the space early.
Ausovi addresses this by embedding Intellectual Property Strategy as a core discipline from target nomination onward. Through early provisional filings, broad genus coverage, method-of-use layering, rigorous FTO analysis, and continuous portfolio orchestration, we create strong, defensible IP estates that maximize value, deter competition, and support high-value partnerships or exits.
Ausovi IP Advantages
- Early provisional filings during target validation and lead generation windows
- Broad composition-of-matter and analog genus protection
- Layered method-of-use, formulation, and combination claims
- Proactive freedom-to-operate monitoring at every milestone
- Strategic divisional, continuation, and international filings
- Portfolio designed for clean due diligence and licensing flexibility
- IP aligned with scientific milestones to maximize patent term and coverage